| Neuromedin U-8 (porcine) | C54H78N16O10 | 1111.32 | 98395-75-6 | H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Neuromedin U-23 (rat) NMU-23 |
C124H180N34O31 | 2643.00 | 117505-80-3 | H-Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Neuromedin U-25 (human) NMU-25 (human) |
C141H203N41O38 | 3080.42 | 312306-89-1 | H-Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Neuromedin U-25 (porcine) | C144H217N43O37 | 3142.57 | 98395-76-7 | H-Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
| Neuronostatin-13 (human, canine, porcine) | C64H110N20O16 | 1415.70 | 1096485-24-3 | H-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-NH2 |
| Neuronostatin-13 (mouse, rat) | C65H112N20O17 | 1445.73 | H-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Thr-NH2 | |
| Neuronostatin-19 (human, canine, porcine) | C90H151N29O25 | 2039.37 | H-Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala-NH2 | |
| Neuronostatin-19 (mouse, rat) | C91H153N29O26 | 2069.40 | H-Ala-Pro-Ser-Asp-Pro-Arg-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Thr-NH2 | |
| Biotinyl-(Des-Bromo)-Neuropeptide B (1-23) (human) Biotinyl-DesBr-NPB-23 (human) |
C117H176N32O32S | 2574.95 | Biotinyl-Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-OH | |
| (Des-Bromo)-Neuropeptide B (1-23) (human) DesBr-NPB-23 (human) |
C107H162N30O30 | 2348.65 | 434897-64-0 | H-Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-OH |
| Neuropeptide FF F-8-F-NH2, NPFF, F-8-F-amide |
C54H76N14O10 | 1081.29 | 99566-27-5 | H-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
| (D-Tyr1,N-Me-Phe3)-Neuropeptide FF | C55H78N14O11 | 1111.31 | 145274-93-7 | H-D-Tyr-Leu-N-Me-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
| RF9 | C26H38N6O3 | 482.63 | 876310-60-0 | 1-Adamantanecarbonyl-Arg-Phe-NH2 |
| Neuropeptide S (1-10) (human) | C42H68N14O14S | 1025.15 | 904910-39-0 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-OH |
| Neuropeptide S (human) NPS (human) |
C93H155N31O28S | 2187.51 | 412938-67-1 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser-OH |
| Neuropeptide S (rat) NPS (rat) |
C95H160N34O27 | 2210.53 | 412938-75-1 | H-Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln-OH |
| Neuropeptide W-23 (human) NPW-23 (human) |
C119H183N35O28S | 2584.05 | 383415-79-0 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-OH |
| Biotinyl-Neuropeptide W-23 (human) Biotinyl-NPW-23 (human) |
C129H197N37O30S2 | 2810.35 | Biotinyl-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-OH | |
| Neuropeptide W-23 (rat) rPPL8 (42-64), Preproprotein L8 (42-64) (rat), rL8, NPW-23 (rat) |
C119H183N35O29S | 2600.05 | 383415-89-2 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-OH |
| Neuropeptide W-30 (human) NPW-30 (human), hPPL8 (33-62), Preproprotein L8 (33-62) (rat), hL8C |
C165H249N49O37S | 3543.17 | 383415-80-3 | H-Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp-OH |
